2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
2026 Obesity & Weight Loss Drug Development Summit
- Program: Integrating Age-Specific Clinical Protocols to Address Unique Physiological Risks in Paediatric & Geriatric Patients, for Safer, More Effective Treatments
- Presentation Title: Combating Sarcopenic Obesity in Geriatrics by Combining GLP-1s with Selective Androgen Receptor Modulators (SARMs) to Prevent Muscle Loss
- Presenter: Mitchell Steiner, MD, Veru Inc.’s Chairman, President & CEO
- Presentation Date & Time: July 15, 2026 at 4:20 PM Eastern Daylight Time
2026 Obesity & Weight Loss Drug Development Summit – Pre-Conference Workshop Day
- Session Title: Moving Beyond BMI & Weight-Loss Endpoints to Advance the Regulatory Frontier & Redefine Clinical Success with the FDA
- Presenters: Gary Barnette, PhD, Veru Inc.’s Chief Scientific Officer
- Session Date & Time: July 14, 2026 at 1:30 PM Eastern Daylight Time